The ROA (Return on Assets) of Inhibikase Therapeutics Inc (IKT) is -27.91%.
ROA (Return on Assets) calculates how much net income a company earns relative to its total assets. It reveals how efficiently a business is managing its resources.
| Date | Value |
|---|---|
| 2024-12-31 | -27.91% |
| 2023-12-31 | -131.17% |
| 2022-12-31 | -72.37% |
| 2021-12-31 | -34.82% |
| 2020-12-31 | -19.28% |
| 2019-12-31 | -14300.00% |
| 2018-12-31 | -75.44% |
| 2017-12-31 | -151.72% |
| 2016-12-31 | -393.75% |